NCT06955676 The Effects of Moderate Intensity Cycle Ergometer vs. Treadmill Training on Physiological Resilience in Older Adults
| NCT ID | NCT06955676 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Nottingham |
| Condition | Older People |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2024-06-01 |
| Primary Completion | 2026-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2024-06-01 with a primary completion date of 2026-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Government guidelines suggest that we should all take part in approximately two and a half hours each week of moderate-intensity aerobic exercise. Older adults are particularly important as their overall health may decline as they get older. Therefore, exercising is important especially for older adults to improve heart and muscle health and functioning in carrying out tasks of daily living. The overall effects of aging on the body can make people less likely to withstand challenges to the body - this is termed 'resilience'. Although aerobic exercise is not super easy and requires continuity, it is not extremely difficult to get used to. However, we still do not know if some types of aerobic exercise are better for you than others at improving resilience. Therefore, this study will look at cycling vs walking to see if one is better at improving resilience in older adults who are 60-80 years old. You will be trained on either a treadmill or cycle ergometer and these exercise sessions will be done over 5 weeks, 3 days a week. Each session will last 40 minutes, start with warm-up and end with cool-down sessions. Assessments will include heart, lung, muscle, and memory and thinking measurements, all of which will be taken before and after the intervention period. This work will help us to better understand how we can improve exercise prescriptions for older adults to sustain their health and functioning in their daily life.
Eligibility Criteria
Inclusion Criteria: * Participant is willing and able to give informed consent for participation in the study * Participants who are able to perform exercises safely and freely * Participants who are 60-80 years old Exclusion Criteria: * Cardiopulmonary diseases except for well-controlled hypertension and asthma * Severe cognitive impairment * Joint disorders avoiding exercise participation * A recent heart attack, unstable angina, or severe heart failure * Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance * Participants who are currently engaging in more than 150 min of moderate-intensity exercise per week or 75 min of vigorous-intensity exercise per week (WHO physical activity recommendations)
Contact & Investigator
Mehmet C Yildirim, PhD
STUDY DIRECTOR
The University of Nottingham
Frequently Asked Questions
Who can join the NCT06955676 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, up to 80 Years, studying Older People. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06955676 currently recruiting?
Yes, NCT06955676 is actively recruiting participants. Contact the research team at beth.phillips@nottingham.ac.uk for enrollment information.
Where is the NCT06955676 trial being conducted?
This trial is being conducted at Derby, United Kingdom.
Who is sponsoring the NCT06955676 clinical trial?
NCT06955676 is sponsored by University of Nottingham. The principal investigator is Mehmet C Yildirim, PhD at The University of Nottingham. The trial plans to enroll 36 participants.